RNA self cleavage inhibitor; antitumor activity An adenosine analog which inhibits ribozyme self cleavage in mammalian cells, EC50 = 0.4 µM (for expression of a luciferase reporter). A potent inhibitor of ER stress-induced XBP1 mRNA splicing. It suppresses thapsigargin-, tunicamycin- and...
Know who made it. See the evidence. Buy through one marketplace.
RNA self cleavage inhibitor; antitumor activity
An adenosine analog which inhibits ribozyme self cleavage in mammalian cells, EC50 = 0.4 µM (for expression of a luciferase reporter). A potent inhibitor of ER stress-induced XBP1 mRNA splicing. It suppresses thapsigargin-, tunicamycin- and 2-deoxyglucose-induced XBP1 mRNA splicing in HeLa cells without affecting ATF6 and PERK activation. Although unable to inhibit IRE1α phosphorylation, it prevented IRE1α-induced XBP1 mRNA cleavage in vitro. It inhibits not only ER stress-induced but also constitutive activation of XBP1 expression in multiple myeloma cell lines as well as in primary patient samples. Displays synergistic effects with bortezomib. Inhibits unfolded protein response and induces apoptosis in pancreatic cancer cells
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
